Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in The Lancet Healthy Longevity? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
TL
The Lancet Healthy Longevity is a gold open-access, multi-disciplinary journal that publishes clinically-focussed longevity and healthy ageing research and review. Its remit spans early-stage clinical research into mechanisms of ageing, epidemiological and societal research on changing populations, clinical trials across disciplines focused but not exclusively on older people, gerontological science, age-specific clinical guidelines, and clinical and policy reviews intended to shape debate in the field.
Looking to publish in The Lancet Healthy Longevity? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
Subject
Geriatrics & Gerontology
Impact Factor
14.6
Quartile
Q1
Open Access Type
Open
ISSN
2666-7568
eISSN
2666-7568
Invitation Only
No
Cost Range
USD 7,860 APC as of Jan 1, 2026
Submission Instructions
The Lancet Healthy Longevity accepts the following article types. Click on an article type to view submission instructions.
Article
Cover Letter
A covering letter should be included with first submissions. The covering letter should explain why the paper should be published in The Lancet Healthy Longevity rather than elsewhere.
Abstract
Articles must include a semistructured abstract. The abstract must not exceed 250 words, although Articles reporting randomised trials must include a structured summary of up to 300 words. The abstract must be semistructured. The abstract must contain the headings Background, Methods, Findings, Interpretation, and Funding.
Manuscript
Articles should be up to 3500 words, or up to 4500 words for randomised controlled trials. Primary research Articles must include a Research in context panel, and randomised trial Articles must include a Randomisation and masking section in Methods plus a trial profile and a baseline characteristics table. Articles must include contributors and declaration of interests statements, a data sharing statement at the end of the manuscript, and a Research in context panel, and any use of generative AI in writing must be disclosed in the acknowledgments.
References
Articles should have no more than 30 references. References must use Vancouver numbering style. References must be cited sequentially as superscript numbers after punctuation, with all six authors listed when there are six or fewer and the first three followed by et al when there are seven or more.
Figures & Tables
Randomised trial Articles must include a trial profile and a table of baseline characteristics. Tables must be supplied in a separate Word document from the main text, while figures are included with first submissions and randomised trial figure files should be submitted as editable files. Kaplan-Meier plots in Articles must include numbers at risk at each timepoint, and in randomised trial Articles they must also include a measure of effect on the graph and must not break the y axis.
Review
Cover Letter
A covering letter must be included with the first submission. The covering letter must explain why the paper should be published in The Lancet Healthy Longevity rather than elsewhere.
Abstract
Reviews must include an abstract. The summary must be no more than 150 words. The summary must be unstructured.
Manuscript
Reviews should be no more than 4500 words. Reviews must include a brief section entitled "Search strategy and selection criteria" that states the sources searched and the criteria for including or excluding studies. The manuscript must include authors' contributions, a "Declaration of interests" statement, funding information, and any AI-use disclosure at the end of the article, and the "Search strategy and selection criteria" section must not contain references.
References
Reviews should have a maximum of 75 references. References must use Vancouver numbering style. References must be cited sequentially as superscript numbers after punctuation, list all authors when there are six or fewer, list the first three followed by et al when there are seven or more, and abbreviate journal names in Index Medicus form.
Figures & Tables
Figures must be included with the first submission, and tables and panels must be included in the manuscript. Tables must be supplied in a separate Word document from the main text and figures must be provided in an editable file type unless they are photographs or MRI scans.
Clinical Picture
Cover Letter
A covering letter should be included with first submissions. The covering letter should explain why the paper should be published in The Lancet Healthy Longevity rather than elsewhere.
Abstract
Abstract requirements are not specified.
Manuscript
The manuscript must include authors’ contributions at the end of the text, a Declaration of interests statement, source of funding information, and an AI-use disclosure in the acknowledgments if generative AI or AI-assisted technology was used in writing.
References
References must use Vancouver numbering style with superscript citation numbers in the text. References must be cited sequentially, list all authors when there are six or fewer, list the first three followed by et al when there are seven or more, and use standard Index Medicus journal abbreviations.
Figures & Tables
Figures should be included with the first submission, while tables must be supplied in a separate Word document rather than within the main text. Table text must be editable, and blackout bars or similar devices must not be used to anonymise patients in clinical images.
Correspondence
Cover Letter
A covering letter should be included with first submissions. The covering letter should explain why the paper should be published in The Lancet Healthy Longevity rather than elsewhere.
Abstract
Abstract requirements are not specified.
Manuscript
Correspondence should be no longer than 400 words. Correspondence should be written in response to previous content published in The Lancet Healthy Longevity and must reach the journal within 4 weeks of publication of the original item. The manuscript must include authors’ contributions at the end of the text, a Declaration of interests subheading at the end of the text, source of funding information, and an acknowledgment statement disclosing any generative AI or AI-assisted technologies used in writing.
References
Correspondence should have no more than five references. References must use Vancouver numbering style. References must be cited sequentially in the text as superscript numbers after punctuation, with up to six authors listed in full or the first three followed by et al for seven or more authors.
Figures & Tables
Only one table or figure is permitted in Correspondence. The manuscript should include tables and panels, figures should be included with first submissions, and tables must be supplied in a separate Word document from the main text. Table text must be editable.
Comment
Cover Letter
A covering letter should be included with the first submission. The covering letter should explain why the paper should be published in The Lancet Healthy Longevity rather than elsewhere.
Abstract
Abstract requirements are not specified.
Manuscript
Unsolicited Comments must not exceed 750 words. The manuscript must include contributors’ statements at the end of the text, a Declaration of interests section, source of funding information, and an acknowledgment statement disclosing any generative AI use in writing.
References
Unsolicited Comments must have no more than ten references. References must use Vancouver numbering style. References must be cited sequentially as superscript numbers after punctuation, with up to six authors listed in full and seven or more abbreviated to the first three followed by et al.
Figures & Tables
Unsolicited Comments may include only one figure, panel, or small table. The manuscript including tables and panels should be included in the submission, and figures should also be submitted.
Recent Publications
Hearing loss, hearing aids, and longevity: from association to intervention
Janet S Choi
10.1016/j.lanhl.2026.100916
View Publication
Hearing loss, hearing-aid use, and mortality risk: individual participant data meta-analysis of population-based studies from Australia, Iceland, and the USA and a replication study from Norway
Chuan-Ming Li, Howard J Hoffman, Bo Engdahl, Bamini Gopinath, Catherine M McMahon, Christa L Themann, Vilmundur Gudnason, Adrian C Davis
10.1016/j.lanhl.2026.100903
View Publication
Making dementia clinical trials more representative
The Lancet Healthy Longevity
10.1016/j.lanhl.2026.100944
View Publication
Social connection and intrinsic capacity in later life across the USA, England, Europe, China, and Japan: a harmonised multicohort longitudinal study
Eric Tsz Chun Lai, Zi-Ting Huang, Hsu-Wen Huang, Hideki Hashimoto, Michael Marmot, Gary Ka Ki Chung, Hong-Jie Yu, Jean Woo
10.1016/j.lanhl.2026.100926
View Publication
Cohort trends in intrinsic capacity in Europe: a population-based longitudinal study
John R Beard, Meimei Chen, Yuanyuan Gu, Katja Hanewald
10.1016/j.lanhl.2026.100906
View Publication
Frequently asked questions
How long does it take to publish?
4 days submission to first decision; 64 days submission to decision after review; 101 days submission to acceptance; 54 days acceptance to online publication
Reformat to The Lancet Healthy Longevity using Livewrite PremiumWhat are the publication costs?
The Lancet Healthy Longevity APC is USD 7,860 as of Jan 1, 2026.
Reformat to The Lancet Healthy Longevity using Livewrite PremiumResearch Topics
Frailty in Older Adults
Dementia and Cognitive Impairment Research
Health Systems, Economic Evaluations, Quality of Life
Chronic Disease Management Strategies
Nutrition and Health in Aging
Health disparities and outcomes
Geriatric Care and Nursing Homes
Global Health Care Issues
Intensive Care Unit Cognitive Disorders
SARS-CoV-2 and COVID-19 Research
Palliative Care and End-of-Life Issues
Aging and Gerontology Research
Health, Environment, Cognitive Aging
Alzheimer's disease research and treatments
Physical Activity and Health
HIV-related health complications and treatments
Blood Pressure and Hypertension Studies
Hip and Femur Fractures
Chronic Obstructive Pulmonary Disease (COPD) Research
Pharmaceutical Practices and Patient Outcomes
Nutritional Studies and Diet
Climate Change and Health Impacts
Vaccine Coverage and Hesitancy
Diabetes, Cardiovascular Risks, and Lipoproteins
COVID-19 and Mental Health